ALEXANDRA MATTOX: Open Payments
NPI 1457832875 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,013 in 50 payments from 14 companies in 2025. Trend: 2023 $1,527 · 2024 $1,599 · 2025 $1,013
Food & beverage: $1,013
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $258 |
| Janssen Biotech, Inc. | 7 | $229 |
| UCB, Inc. | 12 | $151 |
| Actelion Pharmaceuticals US, Inc. | 4 | $84 |
| Amgen Inc. | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Aurinia Pharma U.S., Inc. | 1 | $31 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Invivyd Inc | 1 | $20 |
Products named: TREMFYA, RINVOQ, Bimzelx, ENBREL, SKYRIZI, OPSYNVI, OFEV, ORENCIA.
Industry payments across AL — which companies pay providers there.
